Product Information
OLANZAPINE 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0871 per EA under NDC 33342006844. Its NADAC has been published 604 times since Mar 11, 2015.
FDA first approved this application on Aug 15, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342006844
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA202862FDA Approved
8/15/2014
TE Code
AB
On Market Since
8/22/2014
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE 5 MG TABLET has been published 604 times since Mar 11, 2015, and over the history we have for it it has declined 49.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0871 per EA |
|---|---|
| All-time high | $0.1920 (May 13, 2015) |
| All-time low | $0.0763 (Nov 20, 2024) |
| 52-week high | $0.0915 |
| 52-week low | $0.0858 |
| Median price | $0.1111 |
| Average price | $0.1131 |
| Largest weekly change | +20.2% (Apr 22, 2015) |
| Weeks tracked | 604 |
| Tracking since | Mar 11, 2015 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0871 per EA (NDC 33342006844), effective Sep 30, 2026.
How has the price of OLANZAPINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OLANZAPINE 5 MG TABLET has declined 49.6%. It has been tracked across 604 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for OLANZAPINE 5 MG TABLET?
Since Mar 11, 2015, the NADAC for OLANZAPINE 5 MG TABLET has ranged from a low of $0.0763 (Nov 20, 2024) to a high of $0.1920 (May 13, 2015), with a median of $0.1111 per EA.
Are there cheaper alternatives to OLANZAPINE 5 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLANZAPINE 5 MG TABLET, is $0.0867 per EA — about 0% below OLANZAPINE 5 MG TABLET.
Who manufactures OLANZAPINE 5 MG TABLET?
OLANZAPINE 5 MG TABLET (NDC 33342006844) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.